troleandomycin has been researched along with aflatoxin b1 in 7 studies
Studies (troleandomycin) | Trials (troleandomycin) | Recent Studies (post-2010) (troleandomycin) | Studies (aflatoxin b1) | Trials (aflatoxin b1) | Recent Studies (post-2010) (aflatoxin b1) |
---|---|---|---|---|---|
569 | 26 | 23 | 4,532 | 49 | 1,715 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Eaton, DL; Eddy, AC; Parkinson, A; Ramsdell, HS | 1 |
Guengerich, FP; Shimada, T | 1 |
Halvorson, MR; Parkinson, A; Phillips, TD; Safe, SH | 1 |
Hashimoto, H; Itoh, S; Kamataki, T; Nakagawa, T; Sawada, M; Yokoi, T | 1 |
Eaton, DL; Gallagher, EP; Kunze, KL; Stapleton, PL; Wienkers, LC | 1 |
7 other study(ies) available for troleandomycin and aflatoxin b1
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes.
Topics: Aflatoxin B1; Aflatoxins; Benzoflavones; Biotransformation; Cytochrome P-450 Enzyme System; Humans; Isoenzymes; Microsomes, Liver; Nifedipine; Oxidation-Reduction; Troleandomycin | 1991 |
Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver.
Topics: Aflatoxin B1; Aflatoxins; Antibodies; Benzoflavones; Biotransformation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Immunochemistry; Microsomes, Liver; Mixed Function Oxygenases; Nifedipine; Oxidation-Reduction; Sterigmatocystin; Troleandomycin | 1989 |
Aflatoxin B1 hydroxylation by the pregnenolone-16 alpha-carbonitrile-inducible form of rat liver microsomal cytochrome P-450.
Topics: Aflatoxin B1; Aflatoxins; Animals; Biotransformation; Cytochrome P-450 Enzyme System; Dexamethasone; Enzyme Induction; Hydroxylation; Microsomes, Liver; Mutagenicity Tests; Pregnenolone Carbonitrile; Rats; Sex Factors; Troleandomycin | 1988 |
Fetus-specific CYP3A7 and adult-specific CYP3A4 expressed in Chinese hamster CHL cells have similar capacity to activate carcinogenic mycotoxins.
Topics: Adult; Aflatoxin B1; Aging; Animals; Aryl Hydrocarbon Hydroxylases; Benzoflavones; Biotransformation; Carcinogens; Cell Line; Clone Cells; Cricetinae; Cricetulus; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA, Complementary; Drug Interactions; Fetus; Gene Expression; Guinea Pigs; Humans; Mycotoxins; Sensitivity and Specificity; Transfection; Transformation, Genetic; Troleandomycin | 1995 |
Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Topics: Adolescent; Adult; Aflatoxin B1; Biotransformation; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Female; Humans; Hydroxylation; Lymphocytes; Male; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases; Oxidation-Reduction; Oxidoreductases; Theophylline; Troleandomycin | 1994 |